methylprednisolone has been researched along with Acute Yellow Atrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jain, V; Kathuria, R; Krishnani, N; Kumari, N; Poddar, U; Sarma, MS; Srivastava, A; Yachha, SK | 1 |
1 other study(ies) available for methylprednisolone and Acute Yellow Atrophy
Article | Year |
---|---|
Autoimmune acute liver failure and seronegative autoimmune liver disease in children: Are they different from classical disease?
Topics: Adolescent; Alanine Transaminase; Ascites; Aspartate Aminotransferases; Autoantibodies; Autoimmune Diseases; Azathioprine; Bilirubin; Child; Child, Preschool; End Stage Liver Disease; Female; Glucocorticoids; Hepatic Encephalopathy; Humans; Immunosuppressive Agents; Infant; Jaundice; Liver Failure, Acute; Male; Massive Hepatic Necrosis; Methylprednisolone; Recurrence; Serum Albumin; Severity of Illness Index; Treatment Outcome | 2017 |